Table 3.
Outcomes for topotecan, melphalan and CY regimen
Outcome | Median (range) | |
---|---|---|
Plt >20 × 109/L post transplant | 9 (6–79) | |
ANC >0.5 × 109/L post transplant | 10 (7–11) | |
Mortality | 24 (40) | |
First remission | 16/41 (39) | P 0.51 |
Relapse-refractory | 8/19 (42) | |
Progression | 40 (67) | |
First remission | 29/41 (70) | P 0.384 |
Relapse-refractory | 8/19 (57) | |
4-year OS | 66% | |
4-year PFS | 30% |